Multi-lineage interrogation of the performance characteristics of a split-signal fluorescence in situ hybridization probe for anaplastic lymphoma kinase gene rearrangements: A study of 101 cases characterized by immunohistomorphology on fixed archival tissue

Molecular Diagnosis

Volumn 8, Issue 4, 2004, Pages 213-229

  Tan, Leonard Hwan Cheong ^a   Do, Elaine ^b   Soo, Yong Tan ^c   Siew, Meng Chong ^a   Koay, Evelyn Siew Chuan ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTIBODY;

ANAPLASTIC CARCINOMA; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FETUS WASTAGE; FLUORESCENCE IN SITU HYBRIDIZATION; GANGLIONEUROMA; GENE REARRANGEMENT; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; LYMPHOMA; NEUROECTODERM TUMOR; PREDICTION; PSEUDOTUMOR; REVIEW; SPINDLE CELL CARCINOMA; TISSUE FIXATION; TISSUE SECTION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; DNA PROBES; FEMALE; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOID TISSUE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROTEIN-TYROSINE KINASES; SENSITIVITY AND SPECIFICITY; THRESHOLD LIMIT VALUES;

EID: 22244458603     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.2165/00066982-200408040-00003     Document Type: Review

References (78)

1. Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics: tumors of haematopoeitic and lymphoid tissues. Lyon: World Health Organization Classification of Tumours, International Agency for Research on Cancer, 2001
2. Weisenburger DD, Anderson JR, Diebold J, et al. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Am J Hematol 2001 Jul; 67 (3): 172-8
3. Cataldo KA, Jalal SM, Law ME, et al. Detection of t (2:5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol 1999 Nov; 23 (11): 1386-92
4. Cazals-Hatem D, Andre M, Mounier N, et al. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87). Am J Surg Pathol 2001 Mar; 25 (3): 297-306
5. Warnke RA, Weiss LM, Chan JKC, et al. Classic Hodgkin's disease. In: Rosai J, Sobin LH, editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology. 3rd series, fascicle 14. Washington, DC: US Armed Forces Institute of Pathology, 1994: 227-314
6. Schwarting R, Gerdes J, Durkop H, et al. A new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989 Oct; 74 (5): 1678-89
7. Piris M, Brown DC, Gatter KC, et al. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990 Sep; 17 (3): 211-8
8. Gascoyne RD, Lamant L, Martin-Suberto JI, et al. ALK-positive diffuse large Bcell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003 Oct; 102 (7): 2568-73
9. De Paepe P, Baens M, van Krieken H, et al. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 2003 Oct; 102 (7): 2638-41
10. Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003 Oct; 102 (7): 2642-4
11. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996 Jul; 88 (2): 645-56
12. Fickers M, Theunissen P. Granulocytic sarcoma with expression of CD30. J Clin Pathol 1996 Sep; 49 (9): 762-3
13. Durkop H, Foss HD, Eitelbach F, et al. Expression of the CD30 antigen in non-lymphoid tissues and cells. J Pathol 2000 Apr; 190 (5): 613-8
14. Chan JKC, Cheuk W, Shimizu M. Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am J Surg Pathol 2001 Jun; 25 (6): 761-8
15. Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumors. Mod Pathol 2001 Jun; 14 (6): 569-76
16. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in inflammatory myofibroblastic tumor: a comparative immunohis-tochemical study. Am J Surg Pathol 2001 Nov; 25 (11): 1364-71
17. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002 Sep; 15 (9): 931-8
18. Lamant L, Pulford K, Bischof D, et al. Expression of the ALK tyrosine kinase gene in neuroblastoma. Am J Pathol 2000 May; 156 (5): 1711-21
19. Pillay K, Govendar D, Chetty R. ALK protein expression in rhabdomyosarcomas. Histopathology 2002 Nov; 41 (5): 461-7
20. Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997 Feb; 89 (4): 1394-404
21. Martin-Subero JI, Gesk S, Harder L, et al. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. Anticancer Res 2003 Mar-Apr; 23 (2A): 1139-48
22. Lee WB, Han KJ, Harris CP, et al. Use of FISH to detect chromosomal translocations and deletions: analysis of chromosomal rearrangement in synovial sarcoma cells from paraffin-embedded specimens. Am J Pathol 1993 Jul; 143 (1): 15-9
23. Lu YJ, Birdsall S, Summersgill B, et al. Dual colour fluorescence in-situ hybridization to paraffin-embedded samples to deduce the presence of the der (X)t (X;18) (p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma. J Pathol 1999 Mar; 187 (4): 490-6
24. Kluin PH, Schuuring E. FISH and related techniques in the diagnosis of lymphoma. Cancer Surv 1997; 30: 3-20
25. Gozzetti A, LeBeau MM. Florescence in situ hybridization: uses and limitations. Semin Hematol 2000 Oct; 37 (4): 320-33
26. Tan LHC, Do E, Chong SM, et al. Detection of ALK gene rearrangements in formalin-fixed, paraffin-embedded tissue using a fluorescence in-situ hybridization (FISH) probe: a search for optimum conditions of tissue archiving and preparation for FISH. Mol Diagn 2003 Mar; 7 (1): 27-33
27. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. London: Prentice-Hall, 1994
28. Kleihues P, Cavenee WK. Pathology and genetics: tumours of the nervous system. Lyon: World Health Organisation Classification of Tumours, International Agency for Research on Cancer, 2001
29. Scully RE, Sobin LH. Histological classification of ovarian tumors. World Health Organization international histological classification of tumors. Berlin: Spring-er-Verlag, 1999
30. Shanmugaratnam K, Sobin LH. Histological classification of tumors of the upper respiratory tract and ear. World Health Organization international histological classification of tumors. Berlin: Springer-Verlag, 1991
31. Fletcher CDM, Unni KK, Mertens F. Pathology and genetics: tumours of soft tissue and bone. Lyon: World Health Organisation Classification of Tumours, Interna-tional Agency for Research on Cancer, 2002
32. Tan LHC, Chong SM. Grade II nodular sclerosing Hodgkin lymphoma commonly mimics non-Hodgkin lymphomas with anaplastic morphology: a pathologic review of 42 cases reclassified by current WHO criteria [abstract]. Mod Pathol 2003 Jan; 16 (1): 255A
33. Drexler HG, Gignac SM, von Wasielewski R, et al. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 2000 Sep; 14 (9): 1533-59
34. Bhattacharjee MB, Armstrong DD, Vogel H, et al. Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. Cancer Genet Cytogenet 1997 Aug; 97 (1): 39-53
35. Lee DS, Lee Y-S, Kim Y-R, et al. RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia. Cancer Genet Cytogenet 2002 Dec; 139 (2): 104-8
36. Vaandrager JW, Schuuring E, Raap T, et al. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer 2000 Jan; 27 (1): 85-95
37. Sanchez-Izquierdo D, Siebert R, Harder L, et al. Detection of translocations affecting the BCL-6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia 2001 Sep; 15 (9): 1475-84
38. Castagne C, Muhlematter D, Beyer V, et al. Determination of cutoff values to detect small aneuploid clones by interphase fluoresence in situ hybridization: the Poisson model is a more appropriate approach: should single-cell trisomy 8 be considered a clonal defect? Cancer Genet Cytogenet 2003 Dec; 147 (2): 99-109
39. Meech SJ, McGavran L, Odom LF, et al. Unusual childhood extramedullary hematologic malignancy with natural killer properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion. Blood 2001 Aug; 98 (4): 1209-16
40. Warnke RA, Weiss LM, Chan JKC, et al. Mycobacterial spindle cell pseudotumor of lymph mode and spleen. In: Rosai J, Sobin LH, editors. Tumors of the lymph nodes and spleen: atlas of tumor pathology. 3rd Series, fascicle 14. Washington, DC: US Armed Forces Institute of Pathology, 1994: 444-5
41. Carter D, Patchefsky AS. Tumors and tumor-like lesions of the lung: major problems in pathology. Philadelphia (PA): WB Saunders Co, 1998: 312-22
42. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000 Aug; 157 (2): 377-84
43. Bridge JA, Kanamori M, Ma ZG, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumors. Am J Pathol 2001 Aug; 159 (2): 411-5
44. Cools J, Wlodarska I, Somers R, et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002 Aug; 34 (4): 354-62
45. Ma Z, Hill DA, Collins MH, et al. Fusion of ALK to the ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003 May; 37 (1): 98-105
46. Donner LR, Silva T, Dobin SM. Clonal rearrangement of 15p11.2, 16p11.2, and 16p13.3 in a case of nodular fasciitis: additional evidence favoring nodular fasciitis as a benign neoplasm and not a reactive tumefaction. Cancer Genet Cytogenet 2002 Dec; 139 (2): 138-40
47. Velagaleti GVN, Tapper JK, Panova NE, et al. Cytogenetic findings in a case of nodular fasciitis of subclavicular region. Cancer Genet Cytogenet 2003 Mar; 141 (2): 160-3
48. Yin XL, Hui ABY, Pang JCS, et al. Genome-wide survey for chromosomal imbalances in ganglioglioma using comparative genomic hybridization. Cancer Genet Cytogenet 2002 Apr; 134 (1): 71-6
49. Iwahara T, Fujimoto J, Wen D, et al. Molecular characterization of ALK, a receptor tyrosine kinase expressed in the nervous system. Oncogene 1997 Jan; 14 (4): 439-49
50. Morris SW, Naeve C, Mathew P, et al. ALK, the chromosome 2 gene locus altered by the t (2,5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) [published erratum appears in Oncogene 1997 Dec; 15 (23): 2883]. Oncogene 1997 May; 14 (18): 2175-88
51. Barr FG. The malevolence of matchmaking. Nat Genet 1996 Feb; 12 (2): 113-4
52. Krug U, Ganser A, Koeffler HP. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 2002 May; 21 (21): 3475-95
53. Dong S, Zhu J, Reid A, et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-α fusion protein. Proc Natl Acad Sci U S A 1996 Apr; 93 (8): 3624-9
54. Chen Z, Guidez F, Rousselot P, et al. PLZF-RARα Fusion proteins generated from the variant t (11;17) (q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci U S A 1994 Feb; 91 (3): 1178-82
55. Barrans SL, O'Connor SJM, Evans PAS, et al. Rearrangement of the BCL-6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Br J Haematol 2002 May; 117 (2): 322-32
56. Akasaka T, Ueda C, Kurata M, et al. Nonimmunoglobulin (non-Ig)/BCL-6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL-6. Blood 2000 Oct; 96 (8): 2907-9
57. Von Deimling A, Fimmers R, Schmidt MC, et al. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol 2000 Jun; 59 (6): 544-58
58. Beylot-Barry M, Groppi A, Vergier B, et al. on behalf of the French Study Group of Cutaneous Lymphoma. Characterization of t (2;5) reciprocal translocation and genomic breakpoints in CD30+ cutaneous lymphoproliferations. Blood 1998 Jun; 91 (12): 4668-76
59. Orscheschek K, Merz H, Hell J, et al. Large-cell anaplastic lymphoma-specific translocation (t[2;5][p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? Lancet 1995 Jan; 345 (8942): 87-90
60. Ladetto M, Drandi D, Compagno M, et al. PCR-detectable nonneoplastic BCL-2/IGH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. J Clin Oncol 2003 Apr; 21 (7): 1398-403
61. Rauzy O, Galoin S, Chale JJ, et al. Detection of t (14;18) carrying cells in bone marrow and peripheral blood from patients affected by non-lymphoid diseases. Mol Pathol 1998 Dec; 51 (6): 333-8
62. Aster JC, Kobayashi Y, Shiota M, et al. Detection of the t (14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 1992 Aug; 141 (2): 291-9
63. Biernaux C, Loos M, Sels A, et al. Detection of major BCR-ABL gene expression at a very low level in blood cells of some healthy individuals. Blood 1995 Oct; 86 (8): 3118-22
64. Maes B, Vanhentenrijk V, Wlodarska I, et al. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol 2001 Jun; 158 (6): 2185-93
65. Trumper L, Pfreundschuh M, Bonin FV, et al. Detection of the t (2,5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br J Haematol 1998 Dec; 103 (4): 1138-44
66. Trumper L, Daus H, Merz H, et al. NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis. Ann Oncol 1997; 8 Suppl. 2: S83-7
67. Weber-Matthiesen K, Deerberg-Wittram J, Rosenwald A, et al. Translocation t (2;5) is not a primary event in Hodgkin's disease: simultaneous immunophe-notyping and interphase cytogenetics. Am J Pathol 1996 Aug; 149 (2): 463-8
68. Pressl S, Edwards A, Stephan G. The influence of age, sex and smoking habits on the background level of FISH-detected translocations. Mutat Res 1999 Jun; 442 (2): 89-95
69. Ramsey M, Moore DH, Briner JF, et al. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat Res 1995 Oct; 338 (1-6): 95-106
70. Lindholm C, Tekkel M, Veidebaum T, et al. Persistence of translocations after accidental exposure to ionizing radiation. Int J Radiat Biol 1998 Nov; 74 (5): 565-71
71. Stephan G, Pressl S. Chromosome aberrations in human lymphocytes analysed by fluorescence in situ hybridization after in vitro irradiation, and in radiation workers, 11 years after an accidental radiation exposure. Int J Radiat Biol 1997 Mar; 71 (3): 293-9
72. Sawyer JR, Swanson CM, Koller MA, et al. Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and "jumping translocations" of 1q in a human immunodeficiency virus-related non-Hodgkin's lymphoma. Cancer 1995 Oct; 76 (7): 1238-44
73. Polito P, Canzonieri V, Gloghini A, et al. Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and "jumping translocations" of 1q in a human immunodeficiency virus-related non-Hodgkin's lymphoma. Cancer 1996 Sep; 78 (5): 1142-3
74. Peace BE, Livingston G, Silberstein EB, et al. A case of elevated spontaneous micronucleus frequency derived from chromosome 2. Mutat Res 1999 Nov; 430 (1): 109-19
75. Rubin H. Cancer and complexity: correlations and complementarity. J Surg Oncol 1998 Sep; 69 (1): 4-8
76. American College of Medical Genetics. Standards and Guidelines for Clinical Genetics Laboratories [online]. Available from URL: http://www.acmg.net/Pages/ACMG_Activities/stds/ e.html [Accessed 2003 Aug 13]
77. Demling L. Chaos research, fractals, fuzzy logic. From stereotypes to reality: consequences for medicine. Fortschr Med 1992 Feb; 110 (6): 77-9
78. El-Brawany MA, Nassiri DK. Microemboli detection using ultrasound backscatter. Ultrasound Med Biol 2002 Nov-Dec; 28 (11-12): 1439-46